Intervene, Inc.
7
2
2
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
57.1%
4 terminated/withdrawn out of 7 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
2 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry
Role: lead
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
Role: lead
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System
Role: lead
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
Role: lead
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US)
Role: lead
A Feasibility Study of the ReLeaf Catheter System
Role: lead
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada)
Role: lead
All 7 trials loaded